Author:
Cannon Lesley-Ann Lynnath,Oladimeji Kelechi Elizabeth,Goon Daniel Ter
Abstract
Abstract
Background
Drug-resistant TB (DR-TB) remains a public health concern due to the high morbidity and mortality rates from the disease. The DR-TB is a multifaceted illness with expensive treatment regimens, toxic medications and most often the long duration of treatment constitutes a substantial financial burden on both infected patients and the health system. Despite significant research advances in the diagnosis and treatment, there is a paucity of synthesized evidence on how socio-economic factors are associated with DR-TB. This review aims to address this gap by synthesizing available evidence and data on the common socio-economic drivers of DR-TB infection in Africa.
Methods
A systematic search was conducted on PUBMED and Google Scholar databases from January 2011 to January 2020 using Joanna Briggs Institute’s scoping review approach. An updated search was conducted on 21 September 2020. The eligibility criteria only included systematic reviews and studies with quantitative research methods (cross-sectional, case-control, cohort, and randomized-control trials). Studies conducted in Africa and focusing on socio-economic factors influencing DR-TB burden in African countries were also considered. Data was extracted from all the studies that met the eligibility criteria based on the study’s objectives.
Results
Out of the 154 articles that were retrieved for review, 20 abstracts of these articles met all the eligibility criteria. Of the 20 articles, 17 quantitative and 3 reviews. Two additional articles were found eligible, following the updated search. The following themes were identified as major findings: Social and economic drivers associated with DR-TB. Substance abuse of which, stigma and discrimination were the prominent social drivers. Economic drivers included poverty, financial constraints because of job loss, loss of productive time during hospital admission and treatment costs.
Conclusion
This review has highlighted which socio-economic factors contribute to DR- TB This is relevant to assist DR-TB management program and TB stakeholders in different settings to address identified socio-economic gaps and to reduce its negative impact on the programmatic management of DR TB. Therefore, redirecting strategies with more focus on socio-economic empowerment of DR-TB patients could be one of the innovative solutions to reduce the spread and eliminate DR-TB in Africa.
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference42 articles.
1. Cramm JM, Finkenflügel HJM, Møller V, Nieboer AP. TB treatment initiation and adherence in a south African community influenced more by perceptions than by knowledge of tuberculosis. BMC Public Health. 2010;10(1):72.
2. Mcnally TW, De Wildt G, Meza G, Wiskin CMD. Improving outcomes for multi-drug-resistant tuberculosis in the Peruvian Amazon–a qualitative study exploring the experiences and perceptions of patients and healthcare professionals. BMC Health Serv Res. 2019;19(1):594.
3. World Health Organisation. Global tuberculosis report 2018. France: World Health Organization; 2018.
4. Migliori GB, Richardson MDA, Sotgiu G, Lange C. Multidrug-resistant and extensively drug-resistant tuberculosis in the west. Europe and United States: epidemiology, surveillance, and control. Clin Chest Med. 2009;30(4):637–65.
5. Centre for Disease Prevention and Control. Tuberculosis 2017. Atlanta: US Department of Health and Human Services; 2017.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献